1Roheim PS.Atheros clerosis and lipoprotein metabolism:role of reverse cholesterol transport.Am J Cardiol,1986,57:3.
2Gordon DJ,Probstfield JL,Garrison RJ,et al.High density lipoprotein cholesterol and cardiovascular disease:four prospective American studies.Circulation,1989,79:8～15.
3Stampfer MJ,Frank M,Salvini S,et al.A prospective study of cholesterol,apolipoproteins,and the risk of myocardial infarction.N Engl J Med,1991,325:373～381.
5Miller M,Seidler A,Kwiterovich PO,et al.Long-term predictors of subsequent cardiovascular events with coronary artery disease and desirable levels of plasma total choleaterol.Circulation,1992,86:1165～1170.
6Holme I.Cholesterol reduction and its impact on coronary artery disease and total mortality.Am J Cardiol,1995,76:10～17.
7Shepherd J,Cobbe SM,Ford I,et al.Prevention of coronry heart disease with pravastatin in men with hypercholesterolemia.N Engl J Med,1995,333:1301～1307.
8Byington RP,Jukema JW,Salonen JT,et al.Resuction in cardiovascular events during pravastatin therapy:pooled analysis of clinical events of the pravastatin atherosclerosis intervention program.Circulation,1995,92:2419～2425.
9Sacks FM,Pfeffer MA,Moye LA,et al.The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels.N Engl J Med,1996,335:1001～1009.
10Pedersen TR,Olsson AG,Fargeman O,et al.Lipopritein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian simvastatin survival study (4S).Circulation,1998,97:1453～1460.
7Clapp LH, Finney P, Turcato S, etal. Differential effects of stable prostacyclin muscle proliferation and cyclic AMP generation in human nulmonarv artery[J]. Am J Resnir Cell Mol Biol, 2002, 26 (21) :194-201.
8Weston MW, Isaac BF, Crain C. The use of inhaled prostacyclin in nitroprusside-resistant pulmonary artery hypertension[J]. J Heart Lung Transplant, 2001,20(12) : 1340-1344.
9Lei B, Adachi N, Nagaro T, et al. Nitric oxide production in the Cal field of the gerbil hippocampus after transient forebrain ischemia: effects of 7-nitroindazole and NG-nitro-L-arginine methyl ester [J]. Stroke, 1999,30(3): 669-677.
10Schieffer B, Bunte C, Witte J, et al. Comparative effects of ATI- antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease[J]. J Am Coll Cardiol, 2004, 44(2) : 362-368.
